BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34251442)

  • 1. Compliance With Cannabis Act Regulations Regarding Online Promotion Among Canadian Commercial Cannabis-Licensed Firms.
    Sheikhan NY; Pinto AM; Nowak DA; Abolhassani F; Lefebvre P; Duh MS; Witek TJ
    JAMA Netw Open; 2021 Jul; 4(7):e2116551. PubMed ID: 34251442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of social media compliance with cannabis advertising regulations: evidence from recreational dispensaries in Illinois 1-year post-legalization.
    Marinello S; Valek R; Powell LM
    J Cannabis Res; 2024 Jan; 6(1):2. PubMed ID: 38173010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of social media platform policies that address cannabis promotion, marketing and sales.
    Berg CJ; LoParco CR; Cui Y; Pannell A; Kong G; Griffith L; Romm KF; Yang YT; Wang Y; Cavazos-Rehg PA
    Subst Abuse Treat Prev Policy; 2023 Jun; 18(1):35. PubMed ID: 37337216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing sentiments and themes on cannabis in Canada using 2018 to 2020 Twitter data.
    Najafizada M; Rahman A; Donnan J; Dong Z; Bishop L
    J Cannabis Res; 2022 Apr; 4(1):22. PubMed ID: 35418169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extent of energy drink marketing on Canadian social media.
    Ayoub C; Pritchard M; Bagnato M; Remedios L; Potvin Kent M
    BMC Public Health; 2023 Apr; 23(1):767. PubMed ID: 37098495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis Industry Marketing Violations in Washington State, 2014-2019.
    Carlini BH; Garrett S; Firth C; Pinsky I
    J Stud Alcohol Drugs; 2022 Jan; 83(1):18-26. PubMed ID: 35040756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis Advertising Policies in the United States: State-Level Variation and Comparison with Canada.
    Allard NC; Kruger JS; Kruger DJ
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):505-509. PubMed ID: 36459118
    [No Abstract]   [Full Text] [Related]  

  • 8. Active cannabis marketing and adolescent past-year cannabis use.
    Trangenstein PJ; Whitehill JM; Jenkins MC; Jernigan DH; Moreno MA
    Drug Alcohol Depend; 2019 Nov; 204():107548. PubMed ID: 31550611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Marijuana Advertising on Weedmaps, a Popular Online Directory.
    Bierut T; Krauss MJ; Sowles SJ; Cavazos-Rehg PA
    Prev Sci; 2017 Feb; 18(2):183-192. PubMed ID: 27534665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social Norms for Cannabis Use After Nonmedical Legalization in Canada.
    Winfield-Ward L; Hammond D
    Am J Prev Med; 2024 May; 66(5):809-818. PubMed ID: 38128676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to Cannabis Marketing in Social and Traditional Media and Past-Year Use Among Adolescents in States With Legal Retail Cannabis.
    Whitehill JM; Trangenstein PJ; Jenkins MC; Jernigan DH; Moreno MA
    J Adolesc Health; 2020 Feb; 66(2):247-254. PubMed ID: 31708374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of voluntary policies and commitments in restricting unhealthy food marketing to Canadian children on food company websites.
    Vergeer L; Vanderlee L; Potvin Kent M; Mulligan C; L'Abbé MR
    Appl Physiol Nutr Metab; 2019 Jan; 44(1):74-82. PubMed ID: 30273499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Advertising Violations: A Longitudinal Trend Analysis of FDA Enforcement Letters from 2005 to 2019.
    Zagrodney KAP; Sheikhan NY; Pinto A; Sheikhan T; Witek TJ
    Pharmaceut Med; 2021 Jan; 35(1):31-38. PubMed ID: 33453042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marijuana and Glaucoma: A Social Media Content Analysis.
    Jia JS; Mehran N; Purgert R; Zhang QE; Lee D; Myers JS; Kolomeyer NN
    Ophthalmol Glaucoma; 2021; 4(4):400-404. PubMed ID: 33242684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps.
    Kilmer B
    Am J Drug Alcohol Abuse; 2019; 45(6):664-672. PubMed ID: 31264899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recreational cannabis legalization and immigration enforcement: a state-level analysis of arrests and deportations in the United States, 2009-2020.
    Bruzelius E; Martins SS
    BMC Public Health; 2024 Apr; 24(1):936. PubMed ID: 38561706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five Years After Cannabis Legalization, Is It Time to Ease Restrictions on Promotion?
    Crépault JF; Rueda S; Tang V
    Healthc Policy; 2024 Feb; 19(3):21-28. PubMed ID: 38721730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Toques to Tokes: Two challenges facing nationwide legalization of cannabis in Canada.
    Bear D
    Int J Drug Policy; 2017 Apr; 42():97-101. PubMed ID: 28377052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social Media Posts by Recreational Marijuana Companies and Administrative Code Regulations in Washington State.
    Moreno MA; Gower AD; Jenkins MC; Scheck J; Sohal J; Kerr B; Young HN; Cox E
    JAMA Netw Open; 2018 Nov; 1(7):e182242. PubMed ID: 30646364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.